GlassScriptPhysician profile
Indranill Basu Ray
NPI 1538391446
$74,104.35
in general payments reported to CMS, 2019-2025
15 companies · $4,034 in 2025
The $4,034 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $4,470 · 2021: $140 · 2022: $10K · 2023: $43K · 2024: $1,407 · 2025: $4,034.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $38K · Travel and Lodging: $4,788 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,000 · Food and Beverage: $1,817 · Education: $70.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $38,400.00 |
| Travel and Lodging | $4,788.21 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,000.00 |
| Food and Beverage | $1,817.11 |
| Education | $70.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $51,237.29 | 2019-2025 | Mediguide, Jeti Peripheral Catheter, Aveir |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $11,152.03 | 2019-2023 | Lifevest |
| Medtronic Vascular, INC. | $5,730.63 | 2019 | |
| Medtronic, INC. | $2,692.43 | 2023-2025 | Evera Mri Xt Dr Surescan, Selectsecure, Aurora Ev-Icd Mri Surescan |
| Biosense Webster, INC. | $2,066.12 | 2019-2025 | Carto 3 |
| Medical Device Business Services, INC. | $707.09 | 2019-2023 | Carto 3 |
| Boston Scientific Corporation | $134.11 | 2019-2021 | |
| Medtronic USA, INC. | $124.96 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $75.00 | 2019 | |
| Impulse Dynamics (USA) INC. | $71.08 | 2023 | Optimizer |
| Novo Nordisk INC | $50.00 | 2024 | Wegovy |
| E.R. Squibb & Sons, L.L.C. | $26.36 | 2019-2020 | |
| Ge Healthcare | $24.02 | 2022 | |
| Cvrx, INC. | $6.74 | 2025 | Barostim Neo System |
| Elutia, INC. | $6.49 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Indranill Basu Ray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.